Christina Benninger, M.S.N., APRN, FNP-BC, AGACNP-BC explains the pulmonary hypertension (PH) diagnostic process and what the test results can provide to clinicians. Find out why understanding the results of echocardiograms, right heart catheterizations and other imaging techniques and lab tests is essential to determining effective PH treatment.
Gillian Leung, PharmD, BCCP; Yash Kothari, M.D. cover common side effects of pulmonary hypertension (PH) medications. Drs. Leung and Kothari share tips for managing undesirable effects to get the most out of PH therapy.
J. Wes McConnell, M.D., explains how research process and can lead to promising clinical trials for new therapies and how patient registries can advance pulmonary hypertension. Dr. McConnell also shares news about how to participate in regional clinical trials.
Pulmonary hypertension experts Anna Hemnes, M.D., and Evan Brittain, M.D., M.Sc., moderate a panel discussion on the latest advances in pulmonary hypertension (PH) research.
In this webinar, Laura Nowicki, RN, and PHA staff answer insurance questions. Questions from this webinar were collected and will be added to a follow-up FAQ document to ensure as many questions are answered as possible.
Danielle Burkett, CMA, shares Medicare insights and her knowledge from working with insurance companies and specialty pharmacies for over seven years. Learn what experts wish their patients knew about Medicare and get tips on navigating common Medicare plan challenges.
Danielle Burkett, CMA, covers the basics of Medicare and when Part A, B, C and D are used. Learn how to choose a Part D plan and understand your drug formulary. In addition, learn who needs Medicare Part C, also known as a Medicare Advantage plan.
Jaeger Spratt discusses insurance 101 terms, provides open enrollment advice and important dates for 2022. Learn how to choose an insurance plan that works for you.
Stephen Mathai, M.D., M.H.S, discusses scleroderma and how it’s characterized in the body. Dr. Mathai also talks about the risk of developing pulmonary arterial hypertension or interstitial lung disease related to scleroderma.
Stephen Mathai, M.D., M.H.S, discusses the importance of working with your health care team when treating pulmonary hypertension (PH) and connective tissue disease. Dr. Mathai gives an overview of considerations that should be evaluated when making treatment decisions for patients with connective tissue diseases and pulmonary hypertension.
Part 1 of Drug Discovery from Lab to Consumer presented by Roham Zamanian, MD discusses the complex, time-consuming and costly process of developing safe, effective drugs. Learn about the full life-cycle of drug development, from inception in the laboratory through clinical trials to FDA approval.
Part 2 of Drug Discovery from Lab to Consumer presented by Roham Zamanian, MD, FCCP answers questions and provides insight on the available PAH therapies, targeted treatments and clinical trials during this Q&A portion.
Part 1 of Understanding the PH Drug Pipeline presented by Pulmonologist Anna R. Hemnes, M.D, provides insight on available PAH therapies, the biological pathways through which drugs are targeted and new treatments in the drug development pipeline.
Part 2 of Understanding the PH Drug Pipeline presented by Pulmonologist Anna Hemnes, MD answers questions and provides insight on the available PAH therapies, the biological pathways targeted and new treatments in the drug development pipeline during this Q&A portion.
Stephen Mathai, MD, MHS discusses different types of connective tissue disease including lupus, Sjogren’s syndrome, polymyositis, and rheumatoid arthritis and the associated risk of having pulmonary hypertension.
Stephen Mathai, MD, MHS discusses connective tissue disease and the various diagnostic tests used to assess patients with connective tissue disease for pulmonary hypertension.
Eric D. Austin, M.D., MSCI discusses the ways that PH affects children and answers questions regarding the management, diagnosis, and treatment of pediatric patients.
Ioana R. Preston, M.D. addresses personal issues that affect female patients with PH and identifies creative ways for patients with physical or functional limitations to have meaningful intimate relationships. The presentation provides strategies to help women feel more comfortable with their bodies, improve self-image, enhance intimate relationships, and feel more comfortable in sexual experiences.
Emily Griffin, M.S., C.G.C, a genetic counselor from Columbia University Irving Medical Center explains the basics of a genetic counseling session including what to expect and how to prepare for an appointment.
Stephen Mathai, MD, MHS explains the relationship that exists between pulmonary hypertension and connective tissue disease.
Stephen Mathai, MD, MHS discusses the various risks related to developing pulmonary hypertension if you have connective tissue disease.